Buscar
01/01/2022
Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and Challenges
Redondo, S, Esquirol, A, Novelli, S, Caballero, AC, Garrido, A, Onate, G, Lopez, J, Moreno, C, Saavedra, SD, Granell, M, Briones, J, Sierra, J, Martino, R, Garcia-Cadenas, I. Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and Challenges. Transplantation And Cellular Therapy. 2022; 28(1)DOI:10.1016/j.jtct.2021.10.015. PMID:34757054. IF:3.200(Q2/5D).
01/01/2022
CLL-477 Historical Trends in the Front-Line Treatment in Patients With Chronic Lymphocytic Leukemia: Experience from a European Center
Arguello-Tomas M., Albiol N., Jara P., Sierra J., Mora A., Moreno C.. CLL-477 Historical Trends in the Front-Line Treatment in Patients With Chronic Lymphocytic Leukemia: Experience from a European Center. Clinical Lymphoma Myeloma & Leukemia. 2022; 22DOI:10.1016/S2152-2650(22)01349-0. PMID:36163896. IF:(Q/D).
01/01/2022
CT-275 Incidence and Characteristics of Chronic GVHD in Haploidentical Stem-Cell Transplantation With Post-Transplantation Cyclophosfamide: Experience of the Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH-TC)
Santos M.F., Almorox R.B., Solan L., Lopez O., Gallardo A., Garcia-Avila S., Esquirol A., Ferra C., Martin A., Garcia A., Perez E., Colorado M., Cortes M., Cabrero M., Gayoso J., Yañez L., Pascual M.J., Heras I.D.L., Diez J.L., Caballero M.D., Kwon M., Corral L.L.. CT-275 Incidence and Characteristics of Chronic GVHD in Haploidentical Stem-Cell Transplantation With Post-Transplantation Cyclophosfamide: Experience of the Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH-TC). Clinical Lymphoma Myeloma & Leukemia. 2022; 22DOI:10.1016/S2152-2650(22)01659-7. PMID:36164212. IF:(Q/D).
01/01/2022
CLL-106 First Prospective Data on Minimal Residual Disease Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for First-Line Treatment of CLL in Older Adult or Unfit Patients: The GLOW Study
Munir T., Moreno C., Owen C., Follows G., Benjamini O., Janssens A., Levin M.-D., Osterborg A., Robak T., Simkovic M., Stevens D., Voloshin S., Vorobyev V., Yagci M., Ysebaert L., Qi Q., Steele A., Schuier N., Baeten K., Caces D.B., Niemann C., Kater A.. CLL-106 First Prospective Data on Minimal Residual Disease Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for First-Line Treatment of CLL in Older Adult or Unfit Patients: The GLOW Study. Clinical Lymphoma Myeloma & Leukemia. 2022; 22DOI:10.1016/S2152-2650(22)01322-2. PMID:36163867. IF:(Q/D).
01/01/2022
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial
Moreno C., Greil R., Demirkan F., Tedeschi A., Anz B., Larratt L., Simkovic M., Novak J., Strugov V., Gill D., Gribben J.G., Kwei K., Dai S., Hsu E., Dean J.P., Flinn I.W.. First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial. HAEMATOLOGICA. 2022; 107(9)DOI:10.3324/haematol.2021.279012. PMID:35021599. IF:10.100(Q1/2D).
01/01/2022
Correction: The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years (Leukemia, (2022), 36, 6, (1646-1653), 10.1038/s41375-022-01563-8)
Bazarbachi A., Boumendil A., Finel H., Khvedelidze I., Romejko-Jarosinska J., Tanase A., Akhtar S., Ben Othman T., Ma’koseh M., Afanasyev B., El-Cheikh J., Briones J., Gülbas Z., Hamladji R.-M., Elverdi T., Blaise D., Martínez C., Alma E., Halaburda K., Sousa A.B., Glass B., Robinson S., Montoto S., Sureda A.. Correction: The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years (Leukemia, (2022), 36, 6, (1646-1653), 10.1038/s41375-022-01563-8). LEUKEMIA. 2022; 36(8)DOI:10.1038/s41375-022-01639-5. PMID:35840758. IF:11.400(Q1/1D).
01/01/2022
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia
Barr P.M., Owen C., Robak T., Tedeschi A., Bairey O., Burger J.A., Hillmen P., Coutre S.E., Dearden C., Grosicki S., McCarthy H., Li J.-Y., Offner F., Moreno C., Zhou C., Hsu E., Szoke A., Kipps T.J., Ghia P.. Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia. Blood Advances. 2022; 6(11)DOI:10.1182/bloodadvances.2021006434. PMID:35377947. IF:7.500(Q1/2D).
01/01/2022
Medicina de precisión en leucemia linfática crónica: Análisis de coste-efectividad de nuevas combinaciones dirigidas
Meijide J.B.. Medicina de precisión en leucemia linfática crónica: Análisis de coste-efectividad de nuevas combinaciones dirigidas. Farmacia Hospitalaria. 2022; 46(3)DOI:10.7399/fh.13280. PMID:36183201. IF:(Q/D).
01/01/2022
Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort
Medrano-Martorell, S, Capellades, J, Jimenez-Conde, J, Gonzalez-Ortiz, S, Vilas-Gonzalez, M, Rodriguez-Campello, A, Ois, A, Cuadrado-Godia, E, Avellaneda, C, Fernandez, I, Merino-Pena, E, Roquer, J, Marti-Fabregas, J, Giralt-Steinhauer, E. Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort. EUROPEAN RADIOLOGY. 2022; 32(1)DOI:10.1007/s00330-021-08106-2. PMID:34117555. IF:5.900(Q1/2D).
01/01/2022
The Role of Vascular Imaging atReferral Centers in the Drip and Ship Paradigm
Flores, A, Sero, L, Gomez-Choco, M, Ustrell, X, Pellise, A, Vinas, J, Rodriguez, P, Monterde, A, Castilho, G, Rubiera, M, Amaro, S, Padros, MAF, Cardona, P, Marti-Fabregas, J, Molina, CA, Serena, J, Jimenez-Fabrega, FX, Purroy, F, Zaragoza-Brunet, J, Cocho, D, Palomeras, E, Kuprinski, J, Mas, N, Hernandez-Perez, M, Sanjurjo, E, Carrion, D, Costa, X, Barcelo, M, Monedero, J, Catena, E, Rybyeba, M, Diaz, G, de la Ossa, NP, Ribo, M. The Role of Vascular Imaging atReferral Centers in the Drip and Ship Paradigm. Journal of Stroke & Cerebrovascular Diseases. 2022; 31(1)DOI:10.1016/j.jstrokecerebrovasdis.2021.106209. PMID:34794029. IF:2.500(Q3/7D).
01/01/2022
Frequency and patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial
Sharma, M, Smith, EE, Pearce, LA, Shoamanesh, A, Perera, KS, Coutts, SB, Damgaard, D, Ameriso, SF, Rha, JH, Modrau, B, Yoon, BW, Romano, M, Messe, SR, Barlinn, J, Lambeck, J, Saad, F, Berkowitz, SD, Mundl, H, Connolly, SJ, Hart, RG, Marti-Fabregas, J, O'Donnell, MJ. Frequency and patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial. STROKE. 2022; 53(1)DOI:10.1161/STROKEAHA.120.032976. PMID:34538089. IF:8.300(Q1/1D).
01/01/2022
State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease
Hampel, H, Shaw, LM, Aisen, P, Chen, C, Lleo, A, Iwatsubo, T, Iwata, A, Yamada, M, Ikeuchi, T, Jia, JP, Wang, HL, Teunissen, CE, Peskind, E, Blennow, K, Cummings, J, Vergallo, A. State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2022; 18(1)DOI:10.1002/alz.12372. PMID:34043269. IF:14.000(Q1/1D).
01/01/2022
Prevalence and longitudinal clinical outcomes of negative, moderate, and advanced 18F-flortaucipir PET visual patterns in aging and Alzheimer’s disease
Moscoso A., Heeman F., Camacho V., van Essen M., Grothe M.J., Lin L., Mainta I., Ribaldi F., Devous M.D., Sr., Pontecorvo M.J., Frisoni G.B., Garibotto V., Schöll M.. Prevalence and longitudinal clinical outcomes of negative, moderate, and advanced 18F-flortaucipir PET visual patterns in aging and Alzheimer’s disease. ALZHEIMERS & DEMENTIA. 2022; 18DOI:10.1002/alz.068009. PMID:. IF:(Q/D).
01/01/2022
Relationship between [18F]flortaucipir PET visual patterns and neurodegeneration
Heeman F., Moscoso A., Camacho V., van Essen M., Grothe M.J., Lin L., Mainta I., Ribaldi F., Devous M.D., Sr., Pontecorvo M.J., Frisoni G.B., Garibotto V., Schöll M.. Relationship between [18F]flortaucipir PET visual patterns and neurodegeneration. ALZHEIMERS & DEMENTIA. 2022; 18DOI:10.1002/alz.067143. PMID:. IF:(Q/D).
01/01/2022
Factores asociados con mortalidad a corto plazo en personas que viven en residencias atendidas en servicios de urgencias: resultados del estudio multicéntrico Caregency
Afonso-Argilés F.J., Comas Serrano M., Blázquez-Andión M., Castells Oliveres X., Cirera Lorenzo I., García Pérez D., Gómez Roldán J.M., Pujadas Lafarga T., Ichart Tomás X., Puig-Campmany M., Rizzi M.A., Sinfreu Pujol A., Tejero Cano I., Vena Martínez A.B., Villanueva Sánchez H., Renom-Guiteras A.. Factores asociados con mortalidad a corto plazo en personas que viven en residencias atendidas en servicios de urgencias: resultados del estudio multicéntrico Caregency. EMERGENCIAS. 2022; 34(6)DOI:. PMID:36625693. IF:5.500(Q1/2D).
01/01/2022
Observación en urgencias previa a la hospitalización en pacientes con insuficiencia cardiaca aguda: Impacto sobre el pronóstico a corto plazo
Díez M.P.L., Llorens P., Martín-Sánchez F.J., Gil V., Jacob J., Herrero P., Llauger L., Tost J., Aguirre A., Garrido J.M., Vega J.A., Fuentes M., Alonso M.I., Grima M.L.L., Piñera P., Romero R., Lucas-Imbernón F.J., Andueza J.A., Povar J., Richard F., Sánchez C., Miró Ò., Gil C., Alonso H., Pérez-Llantada E., García G.L., Cadenas M.S., Escoda R., Aguiló S., Millán J., Pavón J., González N.C., Noval A., Rodríguez R.C., Reyes J.A.V., López-Grima M.L., Valero A., Juan M.Á., Pedragosa M.A., Masó S.M., Díaz L.E.C., Ruiz F., Franco J.M., Mecina A.B., Berenguer M., Donea R., Ramón S.S., Rodríguez V.C., Nicolás J.A.S., Aragüés P.L., Gárate R.T., Rodríguez E.Á., Alquézar-Arbé A., Rizzi M.A., Herrera S., Roset A., Cabello I., Haro A., Pérez J.M.Á., Puente P.H., Álvarez J.V., García B.P., García M.G., González M.S., Jiménez I., Hernández N., Brouzet B., Espinosa B., Gil A., García T., Jodar M.D., Del Cerro V.Á.M., López N., Odeh S., Merlo M., Ruíz M., Serralta M.T.L., Jave L.E.C., Arriaga B.A., Bergua B.S., Mojarro E.M., Jiménez B.S.A., Bécquer L.T., García L.L., Lasalle G.C., Urbano C.A., Soto A.B.G., Padial E.D., Ferrer E.S., Múñoz M.A., Gaya R., Bibiano C., Mir M., Rodríguez B., Carballo J.L., Rodríguez-Adrada E., Miranda B.R., Martín M.V., Casanova P.C., Alvarós J.E.. Observación en urgencias previa a la hospitalización en pacientes con insuficiencia cardiaca aguda: Impacto sobre el pronóstico a corto plazo. EMERGENCIAS. 2022; 34(5)DOI:. PMID:36217929. IF:5.500(Q1/2D).
01/01/2022
Sociodemografía, comorbilidad y situación funcional basal de los pacientes mayores atendidos en urgencias durante la pandemia de COVID y su relación con la mortalidad: análisis a partir de la cohorte EDEN-Covid
Del Castillo J.G., Jacob J., García-Lamberechts E.J., Salmerón P.P., Alquézar-Arbé A., Llorens P., Jiménez S., Espinosa F.B.Q., Aguiló S., Gil-Rodrigo A., Alonso C.F., Burillo-Putze G., Fernández B.E., Méndez C.S., Vela M.I., Motto E.Q., Cho J.-U.H., Llopis F., Marrón R., Martín S.G., Aguilera C.L., González X.A., Rizzi M.A., Llauger L., Olagüenaga A.M., Vaswani-Bulchand A., Esquivel P.P., Nicolás J.A.S., Fernández E.C., Escolano E.R., García A.C., Salgado F.F., Miró Ò.. Sociodemografía, comorbilidad y situación funcional basal de los pacientes mayores atendidos en urgencias durante la pandemia de COVID y su relación con la mortalidad: análisis a partir de la cohorte EDEN-Covid. EMERGENCIAS. 2022; 34(6)DOI:. PMID:36625692. IF:5.500(Q1/2D).
01/01/2022
Emergence of visual artistic creativity in frontotemporal dementia
Friedberg A., Pasquini L., Diggs R.T., Glaubitz E.A., Lopez L., Brown J.A., Rankin K.P., Allen I.E., La Joie R., Iaccarino L., Mundada N.S., Illán-Gala I., Bonham L.W., Yokoyama J.S., Miller Z.A., Rabinovici G.D., Kramer J.H., Rosen H.J., Tempini M.L.G., Seeley W.W., Miller B.L.. Emergence of visual artistic creativity in frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2022; 18DOI:10.1002/alz.065202. PMID:36537928. IF:(Q/D).
01/01/2022
Características sociodemográficas, funcionales y consumo de recursos de la población mayor atendida en los servicios de urgencias españoles: una aproximación desde la cohorte EDEN
Miró Ò., Jacob J., García-Lamberechts E.J., Salmerón P.P., Llorens P., Jiménez S., Burillo-Putze G., Montero-Pérez F.J., Aguiló S., Gil-Rodrigo A., Alonso C.F., Alquézar-Arbé A., Parra-Esquivel P., Bayarri M.J.F., Tejera M.G., Soria J.M., Cirera I., Adroher M., Mojarro E.M., García E.G., Valle B., Salado Á.D., Grispán M.R., Díez M.P.L., Chaib F.B., Mota M.S., García J.P., Sindín G.S., González R.J., Pérez Costa R.A., Sánchez C.E., Zapico A.P., Del Castillo J.G.. Características sociodemográficas, funcionales y consumo de recursos de la población mayor atendida en los servicios de urgencias españoles: una aproximación desde la cohorte EDEN. EMERGENCIAS. 2022; 34(6)DOI:. PMID:36625691. IF:5.500(Q1/2D).
01/01/2022
El anciano frágil en urgencias: principales retos
Puig-Campmany M., Ris-Romeu J.. El anciano frágil en urgencias: principales retos. EMERGENCIAS. 2022; 34(6)DOI:. PMID:36625690. IF:5.500(Q1/2D).
01/01/2022
Aortic Sinus Contrast Retention During TAVR: A Warning Sign Preceding a Potential Thrombotic Complication
Asmarats L., Li C.-H., Millán X., Menduiña I., Fernández-Peregrina E., Gutiérrez-Alonso L., Torres M., Serra A., Arzamendi D.. Aortic Sinus Contrast Retention During TAVR: A Warning Sign Preceding a Potential Thrombotic Complication. JACC. Case reports. 2022; 4(11)DOI:10.1016/j.jaccas.2022.03.031. PMID:. IF:(Q/D).
01/01/2022
New PASCAL Ace implant system in complex percutaneous mitral valve repair
Li, CHP, Asmarats, L, Maestre, ML, Fernandez, E, Serra, A, Arzamendi, D. New PASCAL Ace implant system in complex percutaneous mitral valve repair. REC, interventional cardiology. 2022; 4(1)DOI:10.24875/RECICE.M21000201. PMID:. IF:(Q/D).
01/01/2022
Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device
Ruiz-López A., Li C.-H.P., Valdovinos P., Rodríguez Á., Bonet A., Tauron M., Ligero C., Millan X., Alegret J.M., Viladés D., Arzamendi D.. Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device. JACC. Case reports. 2022; 4(12)DOI:10.1016/j.jaccas.2022.03.021. PMID:. IF:(Q/D).
01/01/2022
Live donor kidney transplantation. Situation analysis and roadmap
Valentin, MD, Hernandez, D, Crespo, M, Mahillo, B, Beneyto, I, Martinez, I, Kanter, J, Calderari, E, Gil-Vernet, S, Sanchez, S, Aguera, ML, Bernal, G, de Santiago, C, Diaz-Corte, C, Diaz, C, Espinosa, L, Facundo, C, Fernandez-Lucas, M, Ferreiro, T, Garcia-Erauzkin, G, Garcia-Alvarez, T, Fraile, P, Gonzalez-Rinne, A, Gonzalez-Soriano, MJ, Gonzalez, E, Gutierrez-Dalmau, A, Jimenez, C, Lauzurica, R, Lorenzo, I, Martin-Moreno, PL, Moreso, F, de Gracia, MC, Perez-Flores, I, Ramos-Verde, A, Revuelta, I, Rodriguez-Ferrero, ML, Ruiz, JC, Sanchez-Sobrino, B, Dominguez-Gil, B. Live donor kidney transplantation. Situation analysis and roadmap. NEFROLOGIA. 2022; 42(1)DOI:10.1016/j.nefro.2021.03.008. PMID:36153903. IF:2.600(Q3/6D).
01/01/2022
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up ?
Casali P.G., Blay J.Y., Abecassis N., Bajpai J., Bauer S., Biagini R., Bielack S., Bonvalot S., Boukovinas I., Bovee J.V.M.G., Boye K., Brodowicz T., Buonadonna A., De Álava E., Dei Tos A.P., Del Muro X.G., Dufresne A., Eriksson M., Fedenko A., Ferraresi V., Ferrari A., Frezza A.M., Gasperoni S., Gelderblom H., Gouin F., Grignani G., Haas R., Hassan A.B., Hindi N., Hohenberger P., Joensuu H., Jones R.L., Jungels C., Jutte P., Kasper B., Kawai A., Kopeckova K., Krákorová D.A., Le Cesne A., Le Grange F., Legius E., Leithner A., Lopez-Pousa A., Martin-Broto J., Merimsky O., Messiou C., Miah A.B., Mir O., Montemurro M., Morosi C., Palmerini E., Pantaleo M.A., Piana R., Piperno-Neumann S., Reichardt P., Rutkowski P., Safwat A.A., Sangalli C., Sbaraglia M., Scheipl S., Schöffski P., Sleijfer S., Strauss D., Strauss S.J., Hall K.S., Trama A., Unk M., van de Sande M.A.J., van der Graaf W.T.A., van Houdt W.J., Frebourg T., Gronchi A., Stacchiotti S., EURACAN and GENTURIS. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up ?. ANNALS OF ONCOLOGY. 2022; 33(1)DOI:10.1016/j.annonc.2021.09.005. PMID:34560242. IF:50.500(Q1/1D).
01/01/2022
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Krolewiecki A., Enbiale W., Gandasegui J., van Lieshout L., Kepha S., Messa Junior A., Bengtson M., Gelaye W., Escola V., Martinez-Valladares M., Cambra-Pellejà M., Algorta J., Martí-Soler H., Fleitas P., Ballester M.R., Doyle S.R., Williams N.A., Legarda A., Mandomando I., Mwandawiro C., Muñoz J.. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Gates Open Research. 2022; 6DOI:10.12688/gatesopenres.13615.1. PMID:. IF:(Q/D).
01/01/2022
The role of ATP-binding cassette transporter genes in the metastatic process of epithelial thyroid carcinoma with aggressive behavior
Revilla G., Moral A., Fuste V., Lerma E., Julve J., Escolà-Gil J.C., Mato E., Pérez J.I., Corcoy R., Paez Espinosa E.V.. The role of ATP-binding cassette transporter genes in the metastatic process of epithelial thyroid carcinoma with aggressive behavior. Unraveling The Complexities Of Metastasis: Transition From A Segmented View To A Conceptual Continuum. 2022; DOI:10.1016/B978-0-12-821789-4.00020-5. PMID:. IF:(Q/D).
01/01/2022
Inequities in the incidence and mortality due to COVID-19 in nursing homes in Barcelona by characteristics of the nursing homes
Torres, ML, Diaz, DP, Oliver-Parra, A, Millet, JP, Cosialls, D, Guillaumes, M, Rius, C, Vasquez-Vera, H. Inequities in the incidence and mortality due to COVID-19 in nursing homes in Barcelona by characteristics of the nursing homes. PLoS One. 2022; 17(6)DOI:10.1371/journal.pone.0269639. PMID:35696404. IF:3.700(Q2/4D).
01/01/2022
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
Mostaza J.M., Suárez-Fernández C., Cosín-Sales J., Gómez-Huelgas R., Brotons C., Araujo F.P., Borrayo G., Ruiz E., Pérez P., Espinosa J., Sobrino J., Posé A., Arroyo Díaz J.A., García Vallejo O., Cubo Romano M.P., Jansen Chaparro S., Cabezón Mariscal J., Rico Corral M.A., Abellán Alemán J., Orozco Beltrán D., Escobar Jimenez L., Valdivieso Felices P., Pedro-Botet Montoya J.C., Masana Marín L., Guijarro C., Díaz Rodríguez Á., Díaz Díaz J.L., De la Peña Fernández A., Coloma Bazán E., Cuenca Acevedo R., Suárez Fernández C., Civeira F., Castellano Vázquez J.M., Mostaza Prieto J.M., Suárez Tembra M., Alfonso Megido J., Castiella Herrero J., Tamarit J.J., Martínez-Hervás Alonso M.Á., Carrasco Franco F.J., Álvarez Sala L., Calderón Sandubete E., Rovira Daudi E., Bonilla Rovira F., Murcia Zaragoza J.M., Cuixart Costa L., Bianchi Llave J.L., Álvarez Sánchez C., Marqués Da Silva P., Cunha V., Santos C., Araujo F., Moura J., Rosas Peralta M.. Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial. BMC Cardiovascular Disorders. 2022; 22(1)DOI:10.1186/s12872-022-03013-w. PMID:36550424. IF:2.100(Q3/8D).
01/01/2022
Telerehabilitation for balance rehabilitation in the subacute stage of stroke: A pilot controlled trial
Salgueiro, C, Urrutia, G, Cabanas-Valdes, R. Telerehabilitation for balance rehabilitation in the subacute stage of stroke: A pilot controlled trial. NEUROREHABILITATION. 2022; 51(1)DOI:10.3233/NRE-210332. PMID:35311721. IF:2.000(Q2/5D).
01/01/2022
SARS-CoV-2 Catalonia contact tracing program: evaluation of key performance indicators
Herrero M., Ciruela P., Mendoza S., Mendioroz J., Jané M., Carmona Parcerisa G., Martinez Mateo A.I., Pequeño Saco S., Leon Garcia A.R., Domenech E., Pericas Escalé C., Barrabeig Fabregat I., Rovira Faixa A., Carol Torrades M., Guadalupe Fernandez V., Bes Montalat N., Follia Alsina M.N., Ferras Prats J., Minguell Verges S., Ferrús Serra G., Godoy Garcia P., Alseda Graells M., Parron Bernabe I., Cirera Viladot A., Rius Gibert C., García de Olalla Rizo P., Pérez Albarracín G., Sala Farre M.-R., Clotet Romero L., Herrero Garcia M., Ciruela Navas P., Mallafré-Larrosa M., Mendoza Funes S., Patsi-Bosch G., Martínez-Solanas È., Mendioroz Peña J., Jané Checa M.. SARS-CoV-2 Catalonia contact tracing program: evaluation of key performance indicators. BMC PUBLIC HEALTH. 2022; 22(1)DOI:10.1186/s12889-022-13695-8. PMID:35858841. IF:4.500(Q2/4D).
01/01/2022
Utilidad del modelo 5MPB-Toledo para predecir bacteriemia en el paciente anciano
Díaz R.R., Tey G.M.G., López O.Á., Martín-Sánchez F.J., Sanz I.H., Arlegui E.A., De Egino I.G.R., Arozena R.P., Gorrotxategi N.S., Telletxea X.E., Nieva L.M., Anza D.V., Erviti M.A., Bustos C.N., Barroso I.M.M., Alba M.C.M., Hostalet F.O., Bautista J.G., Espejo M.A.S., Julián-Jiménez A., Rojas R.N., Rojas I.N., Forero W.E.L., Maganto E.S., Berlanga R.C., Martín P.B., García-Lamberechts E.J., Del Castillo J.G., Jerez-Fernández P., Suarez-Robles M., Ramos-Rey C., Yeguas I.A., Fernández-Revaldería M., Sánchez F.J.M., González F.J.C., Tey J.M.G., Sansone L.H., Andion M.B., Roca M.M., Mateo S.A.H., Alonso M.A., García M.J.D., Ramos Ma.E.B., Marco C.L., Cárdenas G.D., Bernal A.S., Palacio A.F., Vega L.M., Calero L.P., Sánchez T.R., Begoña Mora Ordoñez, De Haro M.L.N., Fernández J.A., Álvarez Kailis O.A.L.S., Díaz B.P., García G.M.G., Urgel A.R., Llopis-Roca F., Roselló S.Q., Morales M.T., Bosch M.M., Tejero A.B., Romero M.O., Saavedra O., Seguí N., Fresco L., Osorio G., Calvo J., Ribot J., Carbonell I., Montalvo E.P., Khozouz Z.I.-M., Pardo R.P., Tafur K.C., Corredor Y.P., Carretero C.P., Pina M.E., De Zarate M.M.-O., Ordeñana I.M., Sánchez A.B., González M.J.M., Pérez E.M., Rasco R.G., Núñez M.A., Del Mar Sousa Reviriego M., López A.B., Ducón L.J.D., Mieles S.V.T., González R.J., Amez J.M.F., Del Real H.V.G., Entrala B.A., De Valderrama M.H.F., Motto E.Q., Castillo E.M., Sandoval A.C., Luán R.R., Sánchez M.J.H., Velasco A.A., García M.J.B., García A.G., Herrero C.R., Del Amo Diego S., Chanovas-Borràs M.R., Maimó M.M., Ariño N.C., Prica C.M., Solà M.P., García M.B., Collado J.M., Lázaro L.S., Soria J.M., Salmerón P.P., Marín S.P., Del Carmen Martínez Cánovas E., Cayuela G.B., Sánchez A.H., Nicolás J.A.S., García A.E., Vidal M.A., Casasola M.C.A., Del Mar Luque De Igunza M., Rodríguez M.C.M., Béliz O.J.S., Gutiérrez A.M., Arana M.B., Ruano O.D., Olano M.M.B., Putze G.B., Vaswani-Bouchald A., García-Pérez C.M., De La Fuente-García C., Rodríguez J.S., Cols E.M., Lázaro M.J., Monné D.P., Álvarez M.M.B., Catalán M.B., Fernández T.L., Saurí N.O., Perez A.C., Grima M.L.L., Mosquera M.G., Ordoño L.P., Prida N.S., Franco L.S., Gil M.E.G., Martínez F.G., Olmeda D.M., Escudero M.J.R., Gamaury A.U., Vila M.A., Frías C.A., Álvarez-Manzanares J., Izquierdo R.L., Castrodeza N.S., Reboul L.Q., Aguirre A.A., Latorre F.M., Cebrian F.A., Bernaola A.A., Inchauspe F.J.E., Gorrotxategi A.M.I., Jiménez P., Orden J.M.L., Monteagudo F.C.B., Ramírez L.M.C., Noriega A.R.L., Montoya M.A.C., Rodríguez G.F., Vela M.I., Escudero S.G., Díez N.A., Valero I.A., Gómez P.Y., Toledo J.E.T., Gamazo-Del Rio J.J., Rodríguez B., Aramburu F.J., Carral O.P., Zárate N.C.F., García B.D., Del Río Paz M.J., Martínez S.B.R., Rodríguez V.A., Manzone E., Pareja R.R., López A.J.M., González A.T., Candela A.F.V., Fernández M.D., Puente P.H., Pérez-Reverte F.R., Más A.M., Saldumbide S.M., Robert N., Mendoza A., Blanco A., Quesada S.F., Ungerer O.T., García R.G., Jiménez F.G., Suarez S.M., Calveiro R.R., Fernández I.L., Novio M.G., Vázquez T.P., González L.G., Fernández E.C., García M.P.L., Comaneci D.M., Del Rio Navarro R., Montes G.M., García E.O., Santos L.S., Peinado R., Borrego B.V., Yglesias P.J.M., Martínez C.H., Pomares N., Altimirias X.L.. Utilidad del modelo 5MPB-Toledo para predecir bacteriemia en el paciente anciano. Infectio. 2022; 26(2)DOI:10.22354/in.v26i2.1011. PMID:. IF:(Q/D).
01/01/2022
Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war
Agulnik A., Kizyma R., Salek M., Wlodarski M.W., Pogorelyy M., Oszer A., Yakimkova T., Nogovitsyna Y., Dutkiewicz M., Dalle J.-H., Dirksen U., Eggert A., Fernández-Teijeiro A., Greiner J., Kraal K., Mueller A., Sramkova L., Zecca M., Wise P.H., Mlynarski W., Avula M., Adyrov M.V., Berlanga P., Blackwood C.A., Bouffet E., Czauderna P.S., de Koning L.A., dos Reis Farinha N.J., Foster W.B., Graetz D.E., Gupta S., Holter W., Hough R.E., Kliuchkivska K., Kolenova A., Kolodrubiec J., Moreira D.C., Mukkada S.T., Mykychak I., Raciborska A., Salman Z.S., Sopilnyak A., Tyupa S., Vinitsky A., Wobst N.M., Miller B.A., Rasul S.S., Rodriguez-Galindo C., Alanbousi I., Alexander S.W., Apel A., Bal W.A., Balwierz W.A., Basset-Salom L., Bastardo Blanco D., Bauer K.J., Bayazitov I.T., Bhakta N.H., Bien E.I., Bieniek K.A., Blair S.J., Bodak K.I., Bordeianu I.M., Braganca J.M., Bucurenci M.S., Budny E.B., Budzyn A., Bumgardner C.C., Burditt R.N., Burnside Clapp V.G., Bykov V., Cañete A., Carnelli M., Cela E., Cepowska Z.P., Chaber R., Cherner-Drieux A., Chubata M., Clough H.M., Czernicka - Siwecka J., Czyzewski K., Dashchakovska O., Dembowska-Baginska B.M., Derwich K., Dommett R., Dorosh O., Drabko K.A., Dragomir M.D., Dworzak M., Dyma S., Earl J.D., English M.W., Evseev D.A., Farren B.S., Fedyk N., Ferneza S., Fox Irwin L.E., Galazkowski R.M., Ganieva G., Garanzha V., Gelman M.S., Godzinski J.K., Goeres A.F., Golban R., Griksaitis M.J., Hampel M.A., Hastings S.G., Heenen D.L., Hill M.C., Holiuk I., Hutnik L.M., Irga-Jaworska N., Istomin O., Janczar S.L., Kacharian A., Kalwak K., Karolczyk G.M., Karpenko N.M., Katsubo H., Kaznowska B.J., Kentsis A., Ketteler P., Kienesberger A., Kiselev R., Kizyma Z., Klymniuk H., Kostiuk Y., Kowalik T., Kozlova O., Kozubenko V., Kramar T., Krawczuk-Rybak M., Kulemzina I., Kurkowska P., Kuzyk A.S., Ladenstein R.L., Laguna P.J., Lassaletta A., Lehmberg K., Leontieva O., Liashenko S., Loizou L.G., Lucchetta S.A., Lupo M.W., Lysytsia L., Lysytsia O., Machnik K.A., Mainland J.A., Matczak K.E., Matysiak M.J., Mayeur P., Minervina A.A., Mishkova V., Mizia-Malarz A.J., Morales La Madrid A., Moreno L., Moskvin V.P., Muszynska-Roslan K.M., Nelson A.J., Ociepa T., Oltolini S., Onipko N., Pappas A., Patel A.B., Patrahau A., Pauley J.L., Pavlenko Y., Pavlovych A., Peregud-Pogorzelski J., Perek-Polnik M., Perez V., Perez-Martinez A., Pikman Y., Pitozzi G., Portugal R.G., Posternak V.V., Prete A., Pritchard-Jones K., Radaelli A., Reeves T., Reinhardt D., Reshetnyak A.V., Rider A.J., Rizzari C., Rizzi D., Rodriguez Hermosillo K.G., Ronenko O., Rostowska A.O., Rudko L., Sakaan F.M., Sakhar N., Savva N.N., Scaccaglia D., Schaeffer E.H., Schneider C.U., Scobie N., Semeniuk O., Shevchyk R., Shuler A.I., Shvets S., Skoczen S.P., Smeal W.J., Sokolowski I., Sonkin A.A., Stepanjuk A.I., Spota A., Sterba J., Styczynski J., Svintsova O., Synyuta A.V., Szczepanski T., Szczucinski P.K., Szmyd B.M., Tasso Cereceda M., Teliuk A., Tomanek I., Topping P., Torrent M., Trelinska J., Troyanovska O., Trubnikova E., Tsurkan L.G., Tsymbalyuk-Voloshyn I., Urasinski T.F., Urbanek-Dadela A., Vasilieva N., Vasilyeva A., Verdú-Amorós J., Vilcu-Bajurean N., Vinitsky L., Volpe G., Vorobel O., Wachowiak J.T., Wasiak M.S., Wiedower L.A., Wuenschel L.I., Wysocki M.S., Yurieva M., Zagurska A., Zakharenko S.S., Zakharenko A.V., Zapotochna K., Zawitkowska J.E.. Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war. Lancet Haematology. 2022; 9(9)DOI:10.1016/S2352-3026(22)00259-9. PMID:36055331. IF:(Q/D).
01/01/2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial
Chastre J., François B., Bourgeois M., Komnos A., Ferrer R., Rahav G., De Schryver N., Lepape A., Koksal I., Luyt C.-E., Sánchez-García M., Torres A., Eggimann P., Koulenti D., Holland T.L., Ali O., Shoemaker K., Ren P., Sauser J., Ruzin A., Tabor D.E., Akhgar A., Wu Y., Jiang Y., DiGiandomenico A., Colbert S., Vandamme D., Coenjaerts F., Malhotra-Kumar S., Timbermont L., Oliver A., Barraud O., Bellamy T., Bonten M., Goossens H., Reisner C., Esser M.T., Jafri H.S., Joannidis M., Klimscha W., De Waele E., Devriendt J., Huberlant V., Depuydt P., Van Boxstael S., Peric M., Kopic J., Hanauer M., Hruby T., Sramek V., Svoboda P., Vymazal T., Novacek M., Annane D., Mira J.-P., Souweine B., Dequin P.-F., Meziani F., Stephan F., Nseir S., Gibot S., Schwebel C., Plantefeve G., Diehl J.-L., Richard C., Lamer C., Klouche K., Jaber S., Zakynthinos E., Filntisis G., Zakynthinos S., Koutsoukou A., Saroglou G., Nikolaou C., Vlachogianni G., Pnevmatikos I., Mandragos K., Kremer I., Rozgonyi Z.D., Marjanek Z., Martin-Loeches I., Singer P., Van Heerden V., Carmeli Y., Povoa P., Seoane A.A., Moura P., Gonzalez F., Ramirez P., Marti A.T., Roca R.F., Oteiza L., Escudero D., Piacentini E., Vera P., Tamayo L., Gallego M.A.G., Canas B.S., Figueira I., Leon R., Korten V., Akova M., Wyncoll D., Whitehouse T., Hopkins P., Sim M., Golan Y., Zervos M., Vazquez J., Cherabuddi K., Smulian G., Rouphael N., Welker J., Sims M., Van Duin D., McCarthy T., Polk C.. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial. CRITICAL CARE. 2022; 26(1)DOI:10.1186/s13054-022-04204-9. PMID:36380312. IF:15.100(Q1/2D).
01/01/2022
Comment on: “Surgeon preimplantation macroscopic graft appraisal improves risk stratification of deceased kidney donors: a prospective study”
Piana A., Breda A., Pecoraro A., Prudhomme T., Territo A.. Comment on: “Surgeon preimplantation macroscopic graft appraisal improves risk stratification of deceased kidney donors: a prospective study”. Minerva Urology And Nephrology. 2022; 74(6)DOI:10.23736/S2724-6051.22.05178-3. PMID:36629811. IF:4.900(Q1/2D).
01/01/2022
Outcomes of ureteroscopy for management of stone disease in early and late childhood over a 15-year period
Sinha M., Pietropaolo A., Quiroz Madarriaga Y., de Knecht E.L., Bujons Tur A., Griffin S., Somani B.K.. Outcomes of ureteroscopy for management of stone disease in early and late childhood over a 15-year period. Therapeutic Advances in Urology. 2022; 14DOI:10.1177/17562872221141775. PMID:36568063. IF:2.000(Q3/7D).
01/01/2022
Three-dimensional Model-assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies
Piramide F., Kowalewski K.-F., Cacciamani G., Rivero Belenchon I., Taratkin M., Carbonara U., Marchioni M., De Groote R., Knipper S., Pecoraro A., Turri F., Dell'Oglio P., Puliatti S., Amparore D., Volpi G., Campi R., Larcher A., Mottrie A., Breda A., Minervini A., Ghazi A., Dasgupta P., Gozen A., Autorino R., Fiori C., Di Dio M., Gomez Rivas J., Porpiglia F., Checcucci E., European Association of Urology Young Academic Urologists and the European Secti. Three-dimensional Model-assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies. European Urology Oncology. 2022; 5(6)DOI:10.1016/j.euo.2022.09.003. PMID:36216739. IF:8.200(Q1/1D).
01/01/2022
Comment on “Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis” on behalf of the Young Academic Urologists – Urothelial Cancer Working Group
Afferi L., Gallioli A., Del Giudice F., Pradere B., Soria F., Moschini M.. Comment on “Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis” on behalf of the Young Academic Urologists – Urothelial Cancer Working Group. Minerva Urology And Nephrology. 2022; 74(6)DOI:10.23736/S2724-6051.22.05181-3. PMID:36629814. IF:4.900(Q1/2D).
01/01/2022
Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter Series
Marra G., Agnello M., Giordano A., Soria F., Oderda M., Dariane C., Timsit M.-O., Branchereau J., Hedli O., Mesnard B., Tilki D., Olsburgh J., Kulkarni M., Kasivisvanathan V., Breda A., Biancone L., Gontero P.. Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter Series. EUROPEAN UROLOGY. 2022; 82(6)DOI:10.1016/j.eururo.2022.05.024. PMID:35750583. IF:23.400(Q1/1D).
01/01/2022
Propofol sedation administered by cardiologists in echocardiography studies
Li C.-H., González-Salvado V., Bertolí E., Viladés D., Descalzo M., Carreras F., Leta R., Cinca J., Capellades H., Cueva L., Paniagua P.. Propofol sedation administered by cardiologists in echocardiography studies. Rec: Cardioclinics. 2022; 57(1)DOI:10.1016/j.rccl.2021.02.007. PMID:. IF:(Q/D).